Skip to content

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01975597
Enrollment
8
Registered
2013-11-04
Start date
2013-08-31
Completion date
2014-11-19
Last updated
2023-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Breast Cancer

Brief summary

This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.

Interventions

PROCEDUREBone marrow aspirates and biopsy

Sponsors

University of Michigan Rogel Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with metastatic breast cancer (any site) age 21 or older * Patients willing and able to provide informed consent & perform study procedures * Patients may enroll with recently (with 2 months) progressive tumor burden * Performance status of 0,1 or 2

Exclusion criteria

* Patients unable or unwilling to provide informed consent and or perform study procedures * Patients with active, uncontrolled coagulopathy * Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin * Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy

Design outcomes

Primary

MeasureTime frame
Number of patient that agree to undergo 2 biopsy's strictly for research purposes.At 3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026